University of Chicago Cancer Center — Chicago, Illinois

University of Chicago Cancer Center is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Chicago Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), MDS.

Sponsors: University of Chicago, Astex Pharmaceuticals, Inc., Multiple Myeloma Research Consortium.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago Cancer Center?

University of Chicago Cancer Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago Cancer Center conducted?

University of Chicago Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), MDS.

Is University of Chicago Cancer Center accredited by Crixeo Clinical Trials?

University of Chicago Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.